1 Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows Nov 15, 2024
Read More Medical Pfizer's New Treatment Elranatamab Receives FDA Breakthrough Therapy Designation For Relapsed Or Refractory Multiple Myeloma Nov 26, 2024
Read More Healthy Gastrointestinal Diseases Are On The Rise, How To Fight The "Battle For Your Stomach"? Dec 02, 2024
Read More Apparatus Hutchison Pharmaceuticals Announces Approval Of Cd73 Monoclonal Antibody Mupadolimab In Phase I/Ib Clinical Trial In China Nov 13, 2024
Read More Medical New Targeted Radiotherapy For "Laser-Like" Precision Treatment Of Refractory Prostate Cancer With Fewer Side Effects! Nov 13, 2024
Read More Apparatus New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression Nov 21, 2024
